Kolexia
Demiot Claire-Elise
Pharmacien
Hôpital Dupuytren
Limoges, France
59 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Neuropathies périphériques Névralgie Hyperalgésie Escarre Ulcère Neuropathie des petites fibres Diabète expérimental Diabète Maladies rares

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice.
Pharmaceuticals (Basel, Switzerland)   23 janvier 2024
Interest of a short educational intervention coordinated by community pharmacists for elderly type 2 diabetes patients in a rural area.
Therapie   23 janvier 2024
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy.
Pharmaceutics   20 janvier 2024
Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine.
Toxics   08 décembre 2023
A MOUSE MODEL OF SENSORY NEUROPATHY INDUCED BY A LONG COURSE OF MONOMETHYL-AURISTATINE E TREATMENT
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
NETAZEPIDE, AN ANTAGONIST OF CHOLECYSTOKININ TYPE 2 RECEPTOR, PREVENTS PACLITAXEL-INDUCED SENSORY NEUROPATHY IN MICE
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
ANGIOTENSIN TYPE 2 RECEPTOR, A NEW TARGET, TO PREVENT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
2023 PNS Annual Meeting – Copenhagen, 17‐20 June 2023   09 octobre 2023
A mouse model of sensory neuropathy induced by a long course of monomethyl-auristatin E treatment.
Toxicology and applied pharmacology   05 juillet 2023
Blockade of CCK2R prevents the onset of vincristine-induced sensory neuropathy in mice
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.
Pharmaceutics   16 décembre 2022